Unintended consequences of foreign aid often plague beneficent giving.
A study published in the open-access journal PLoS Medicine
has found that loans to former Soviet Union and Central and Eastern
European countries made by the International Monetary Fund (IMF)
between 1992 and 2002 were linked to a 16.6% rise in death rates from
tuberculosis (TB).
In their analysis, David Stuckler (University of Cambridge, UK) and
colleagues from Yale University, USA, also showed 13.9% increase in the
number of new TB cases per year and a 13.2% increase in the total
number of people with the disease per year - both of which are
associated with IMF loans.
Many of the countries in the study received their first IMF loans
between 1992 and 2002. The authors write that, "According to the IMF,
the objective of these programs is to achieve macroeconomic stability
and economic growth." According to a report from the Center for Global
Development, however, achieving these goals may cause countries
receiving IMF loans to withhold spending on health and social services.
Countries often receive IMF loans contingent on meeting certain
economic targets specified by the IMF. In order to meet these targets,
the countries may reduce social spending - for example, by placing caps
on public wage bills or by privatizing healthcare services.
Stuckler and colleagues analyzed health outcomes data collected by the
World Health Organization (WHO), and IMF data from the World Bank's
World Development Indicators. They developed models that were designed
to test the relationship between TB outcomes and entry to (and exit
from) IMF loan programs. The models statistically controlled for
possible confounding factors, such as the level of economic
development, financial desperation, and HIV/AIDS, to name a few.
Studying the mechanisms that drive the increase in TB death rates, the
researchers found that IMF programs are associated with an 8% decrease
in government spending and a 7% decrease in the number of doctors per
person. In addition, countries receiving loans had less coverage of the
TB control strategy recommended by WHO called "directly observed
treatment, short course" (DOTS). The reduction in TB control
infrastructure made by countries receiving IMF loans could very well be
a main part of the reason for the increase in TB death rates.
The authors conclude that: "The results of this analysis suggest that
the IMF should take into account the potential impact of its programs
on tuberculosis control systems. Although in recent years the IMF has
begun to play a direct role in supporting tuberculosis and HIV/AIDS
control efforts via poverty reduction programs, the IMF should
critically evaluate the indirect effects of its economic programs on
tuberculosis control efforts."
Megan Murray and Gary King (Harvard University, USA) write in an
accompanying commentary that it is difficult to perform robust research
on these types of topics. There are key limitations such as the
non-random assignment of IMF loans and the fact the loans are given to
countries that are already economically - and often socially -
unstable. However, they conclude that, "We are convinced that at least
the authors went very far in testing assumptions and mitigating
uncertainties, and so the study and its conclusions should be taken
seriously."
International Monetary Fund programs and tuberculosis outcomes
in post-communist countries
Stuckler D, King LP, Basu S
PLoS Medicine (2008). 5(7): e143.
doi:10.1371/journal.pmed.0050143
Click
Here to View the Article
The effects of international monetary fund loans on health
outcomes
Murray M, King G
PLoS Medicine (2008). 5(7): e162.
doi:10.1371/journal.pmed.0050162
Click
Here to View Perspective Article
About PLoS Medicine
PLoS Medicine is an open access, freely available
international
medical journal. It publishes original research that enhances our
understanding of human health and disease, together with commentary and
analysis of important global health issues. For more information, visit
plosmedicine
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization
of scientists and physicians committed to making the world's
scientific and medical literature a freely available public resource.
For more information, visit plos
: Peter M Crosta